Spectrum of vivax malaria in pregnancy and its outcome: a hospital- based study by Kailash Chandra Nayak, Mahesh Pal Khatri, Bal Kishan Gupta, Parmendra Sirohi, Vinita Choudhary, Surendra Kumar Verma & Sanjay Beniwal
J Vector Borne Dis 46, December 2009, pp. 299–302
Spectrum of vivax malaria in pregnancy and its outcome: a hospital-
based study
Kailash Chandra Nayak, Mahesh Pal Khatri, Bal Kishan Gupta, Parmendra Sirohi,
Vinita Choudhary, Surendra Kumar Verma & Sanjay Beniwal
Department of Medicine, S.P. Medical College, Bikaner, India
Key words Malaria – Plasmodium vivax – pregnancy
It has been recognized for nearly a century that preg-
nant women are especially prone to severe malaria.
Studies from various countries of Asia regarding
impact of unstable malaria in pregnant women have
shown it to be an important cause of maternal
death1,2, but in India only a limited number of hospi-
tal-based studies have been carried out regarding the
consequences of malaria infection in pregnant
women3–5. Considering the severity of the problem,
we planned to undertake an in-depth prospective
study on impact of Plasmodium vivax malaria in preg-
nancy and its outcome in comparison to non-preg-
nant female patients residing in the same environ-
ment and community. These observations are of
immense clinical significance and are essential for the
theme presented in implementation of global malaria
control programme.
This study was conducted on pregnant and non-preg-
nant female patients suffering from P. vivax malaria
(confirmed by demonstration of asexual phase of
parasite in peripheral blood smear) admitted in clas-
sified malaria wards of PBM Hospital, Bikaner
(Rajasthan), India during 2006–08. Smear positive
cases of only P. vivax infection were included in the
study. Rapid card test for malaria (OptiMal test) was
also performed in every case. Patients with P.
falciparum infection were not included in the study.
Thorough clinical and biochemical examinations were
done in all patients, which included complete blood
counts, liver function tests, blood urea, serum crea-
tinine and urine analysis. Other investigations like
widal test, blood culture, Australia Antigen (HBsAg)
(Positive HBsAg cases were not included) and bru-
cella antibody titre were performed to rule out other
causes of fever1. Fundus and CSF examinations were
done in patients of suspected cerebral malaria.
All pregnant patients were subjected to regular ob-
stetric checkup in antenatal clinic and cases were
followed-up till delivery. Sonography of abdomen
was done in all the pregnant patients and weight of
the fetus and placenta were recorded. Cord blood
smear and fetal blood smear were also taken to see
the evidence of malaria parasite. The Institutional
Ethical Committee of S.P. Medical College, Bikaner
approved the study. All the patients with uncompli-
cated malaria and pernicious syndromes were treated
according to WHO guidelines1. Mortality and morbid-
ity trends were statistically compared in pregnant and
non-pregnant females by applying chi-square test.
The study was conducted on 169 female patients of
P. vivax malaria, which included 25 pregnant females
and 144 non-pregnant females. There was no history
of prior hospitalization and treatment in both the
groups. Duration of fever was 1 to 11 days in both
the groups with mean 5.3 days in pregnant and 5.76
days in non-pregnant women and the difference was
not statistically significant (p >0.05). The incidence
of malaria in pregnancy was found to be more in
primigravida and second gravida (18/25) as compared
to multigravida (7/25). Highest incidence of infec-
tion was observed during 14–28 wk of gestation
(13/25) followed by the period >28 wk (9/25) and
least in period of <14 wk (3/25) of gestation. We J  VECTOR  BORNE  DIS  46, DECEMBER 2009 300
observed high incidence of all pernicious syndromes
of malaria infection in pregnant females in compari-
son to non-pregnant patients. The results of statisti-
cal analysis are shown in Table 1. Out of 25 preg-
nant females, severe anemia was found in 15, hepatic
dysfunction in three, renal failure in two, hypoglyce-
mia in one, acute respiratory distress syndrome
(ARDS) in one, multiorgan dysfunction in one and
thrombocytopenia in 14 cases and in comparison to
144 non-pregnant females where severe anemia was
found in 40 (27.77%), hepatic dysfunction in 11
(7.63%), renal failure in five (3.47%), hypoglycemia
in four (2.77%), ARDS in four (2.77%), multiorgan
dysfunction in five (3.47%) and thrombocytopenia
in 28 (19.44%) cases.
The outcome of pregnancy was worse in primipa-
rous women as compared to multiparous. Normal
pregnancy continued in only two out of 10 primipa-
rous and nine out of 15 multiparous pregnant women.
Other complications of pregnancy, i.e. preterm live
birth  was reported in four, intrauterine death  in one,
stillbirth in two and abortion in one case were re-
ported in primiparous group and preterm live birth
was reported in four, intrauterine death  in one and
abortion in one case was reported in multiparous
group. Majority of fetus (20) were born with low
birth weight of <2.5 kg.  Two fetus were aborted
which were having birth weight <500 g. Out of 25
placenta examined, 18 had weight between 200 and
400 g, two patients who aborted had placental weight
< 200 g and only five had weight >400 g6.
Pregnant women are especially prone to develop se-
vere and complicated malaria1,2. The incidence of
severity of infection and pregnancy related compli-
cations varies according to the level of acquired im-
munity of pregnant women against the infections and
the parity7. In our study, the susceptibility to malaria
infection was found to be high in first and second
pregnancies (18 cases). Similar results were reported
in India which indicate primigravida are associated
with more clinical severity than multigravida in the
areas where transmission rate of malaria is high3,4.
In highly endemic areas the peak level of P. vivax
parasitaemia occurs between 9 and 16 wk of gesta-
tion and then decreases progressively until delivery.
In our study, 13 patients were having 14–28 wk of
gestation at the time of infection. This shows a greater
incidence of malaria infection during second trimes-
ter and is in accordance with earlier studies3,4. The
mechanism of increased susceptibility to malarial in-
fection during pregnancy has not been elucidated but
increased cortisol level, depressed cell mediated im-
munity, altered immune functions of spleen, immune
evasion by parasite and interactions between malaria
parasite and human nutritional status are believed to
play an important role7,8.
Pregnancy is associated with severe P. vivax malaria
Table 1. Incidence of various pernicious syndromes observed among pregnant and non-pregnant groups
Pernicious syndrome Pregnant Non-pregnant Odds ratio Risk ratio Chi-square p-value
n = 25 (%) n =144 (%)
Severe anemia (Hb <5 g%) 15 (60) 40 (27.7) 3.9 2.16 8.66 0.002
Hepatic failure 3 (12) 11 (7.6) 1.64 1.57 – 0.342
  (S. bilirubin >3 mg%)
Renal failure 2 (8) 5 (3.4) 2.41 2.3 – 0.276
  (S. creat. >3 mg%)
Hypoglycemia 1 (4) 4 (2.7) 1.45 1.44 – 0.556
  (Blood glucose <40 mg%)
Thrombocytopenia 14 (56) 28 (19.4) 8.9 4.48 – 0.000005
  (Platelet count <100000)
ARDS 1 (4) 4 (2.7) 1.45 1.44 – 0.556
Multiorgan dysfunction 1 (4) 5 (3.4) 1.158 1.152 – 0.623 301 NAYAK ET AL: VIVAX MALARIA IN PREGNANCY
and increased prevalence of various pernicious syn-
dromes. Multiple organ failure was more common
in pregnant females and associated with grave prog-
nosis. Severe anemia (Hb <5 g%) was more com-
monly seen amongst pregnant group as compared to
non-pregnant females. The mechanism of anemia is
multifactorial and complex involving hemolysis and
inappropriate bone-marrow response3.
Thrombocytopenia (platelet <100,000/l) is an
important complication of P. vivax malaria which is
more pronounced during pregnancy. Severe throm-
bocytopenia (platelets <50,000/l) may be associ-
ated with bleeding tendency and it was observed in
five pregnant patients as compared to only 10 non-
pregnant patients in our study. Similar observations
were reported by other workers8.
Various authors from India9,10 have described
hypoglycemia in severe malaria. The incidence of
hypoglycemia (blood glucose <40 mg%) is also
increased during pregnancy. The possible mechanism
for hypoglycemia in our patients included increased
glucose consumption by host and the parasite11, gly-
cogen depletion and impaired gluconeogenesis12,13.
Malaria leads to significant impact on development
of fetus and placenta and outcome of pregnancy in
areas of unstable transmission. In our study, preterm
live births were seen in eight patients while the inci-
dence of low birth weight babies was seen in 20 cases.
Placental malaria is a significant cause of pregnancy
related complications in the form of abortions, still-
births, premature deliveries and low birth weight
babies. Several investigators have demonstrated an
association between placental infection and low birth
weight. The biologic mechanism by which placental
malaria infection leads to low birth weight is not fully
established5,8.
Limited data are available regarding spontaneous
abortion as a complication of malaria infection. In
our study, two patients had abortion, although vari-
ous authors from other parts of the world have re-
ported that malaria is not an important cause of spon-
taneous abortion in highly endemic areas8. As most
of the reports are from highly endemic areas and have
failed to document a direct association between ma-
ternal malaria and abortions, it seems that the evi-
dence of abortions varies inversely with immunity of
mother9.
Malaria during pregnancy results in increased peri-
natal wastage in the form of maternal deaths and fe-
tal wastage. Pregnant women are likely to have 2–
10 fold higher mortality than non-pregnant women
and few studies in India have also shown high inci-
dence of maternal deaths in cases of malaria3,4 but
we have not observed any maternal death in our study
which may be because of small number of cases, early
recognition and management of the disease.
Thus, our study shows that P. vivax malaria infec-
tion has an adverse effect on progress and outcome
of pregnancy. Therefore, early diagnosis and proper
initiation of therapy can reduce the risk of serious
maternal and fetal complications. As the chances of
acquiring malaria infection are increased during preg-
nancy, measures should be taken to protect preg-
nant women from hazards of malaria infection.
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